Press Releases

26.09.2018 | Nanion Technologies places two SyncroPatch 384PE Instruments for Ion Channel Screening at Charles River Laboratories

LIVINGSTON, N.J., MUNICH, Germany, September 26, 2018: Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients. The instruments will be delivered to Charles River (Cleveland site; former ChanTest) in November of this year and will be used for various ion channel screening & profiling services, including cardiac safety screening, efficacy, and SAR studies.

Andrea Brüggemann, CSO Nanion comments: “Charles River and Nanion Technologies have been successfully collaborating for many years and we are pleased that they have expressed their confidence in our technology through this purchase. I believe that the SyncroPatch 384PE will integrate seamlessly into Charles River Laboratories, where the
flexibility of the instrument will help service their many diverse projects. We are looking forward to our continued collaboration and the new potential challenges it will bring”

Read the full press release here.

Back to Overview

 

New Genedata Screener®APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok